Does systemic antipsoriatic therapy affect the cardiovascular risk?

被引:1
|
作者
Egeberg, A. [1 ,2 ]
机构
[1] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark
[2] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, DK-2900 Hellerup, Denmark
关键词
SEVERE PSORIASIS; COHORT; SKIN;
D O I
10.1111/bjd.14149
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1362 / 1363
页数:2
相关论文
共 50 条
  • [21] How much does hypertension in pregnancy affect the risk of future cardiovascular events?
    Mureddu, Gian Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 (SUPPB) : B111 - B113
  • [22] Does Antiretroviral therapy increase or decrease the risk of cardiovascular disease?
    Fichtenbaum C.J.
    Current HIV/AIDS Reports, 2010, 7 (2) : 92 - 98
  • [23] Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis
    Sigurdardottir, Gunnthorunn
    Ekman, Anna-Karin
    Stahle, Mona
    Bivik, Cecilia
    Enerback, Charlotta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (06) : 1067 - 1075
  • [24] Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus
    Lee, AB
    Godfrey, T
    Rowley, KG
    Karschimkus, CS
    Dragicevic, G
    Romas, E
    Clemens, L
    Wilson, AM
    Nikpour, M
    Prior, DL
    Best, JD
    Jenkins, AJ
    INTERNAL MEDICINE JOURNAL, 2006, 36 (04) : 237 - 243
  • [25] Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?
    Nolan, D
    Watts, GF
    Herrmann, SE
    French, MA
    John, M
    Mallal, S
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (11) : 825 - 832
  • [26] How does intensive therapy to control cardiovascular risk factors affect health-related quality of life in diabetic patients?
    Botija Yaguee, M. Pilar
    Lizan Tudela, Luis
    Gosalbes Soler, Victoria
    Bonet Pla, Alvaro
    Fornos Garrigos, Antonio
    ATENCION PRIMARIA, 2007, 39 (05): : 227 - 233
  • [27] Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
    Haque, S
    Bruce, IN
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (08): : 423 - 430
  • [28] Therapy Insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
    Sahena Haque
    Ian N Bruce
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 423 - 430
  • [29] Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
    Ramsey-Goldman R.
    Nature Clinical Practice Rheumatology, 2005, 1 (2): : 72 - 73
  • [30] Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction
    Hofmann, R.
    Tornvall, P.
    Witt, N.
    Alfredsson, J.
    Svensson, L.
    Jonasson, L.
    Nilsson, L.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (04) : 334 - 345